Sign In / Join

favorite Donate

close

person Sign In / Create Account

HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

HealthTree Study: How Do Myeloma Patients Feel About Using Cannabis?

Dec. 19, 2024

HealthTree Study: How Do Myeloma Patients Feel About Using Cannabis?

Studying Quality of Life With and Without Elotuzumab in Newly Diagnosed Myeloma

Dec. 18, 2024

Studying Quality of Life With and Without Elotuzumab in Newly Diagnosed Myeloma

What Can Be Done to Predict Optimal CAR-T Responses?

Dec. 17, 2024

What Can Be Done to Predict Optimal CAR-T Responses?

Does 24-Hour Urine Testing Add Value to Myeloma Response Results?

Dec. 16, 2024

Does 24-Hour Urine Testing Add Value to Myeloma Response Results?

HealthTree Research: Patients Share their Experiences with Talquetamab Therapy

Dec. 12, 2024

HealthTree Research: Patients Share their Experiences with Talquetamab Therapy

Results from HealthTree Study Presented at ASH 2024: Managing Pain and Opioid Use for Myeloma Patients

Dec. 12, 2024

Results from HealthTree Study Presented at ASH 2024: Managing Pain and Opioid Use for Myeloma Patients

The Best of ASH 2024

Dec. 10, 2024

The Best of ASH 2024

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

Dec. 10, 2024

Effects of Eating Fiber, Plant-Based Diet, Keto Diet, and Smoking on Certain Blood Cancers

Making Research a Reality in AL Amyloidosis: Thanks to You!

Dec. 10, 2024

Making Research a Reality in AL Amyloidosis: Thanks to You!

Landmark Study Shows Daratumumab Significantly Delays Progression in Smoldering Myeloma

Dec. 10, 2024

Landmark Study Shows Daratumumab Significantly Delays Progression in Smoldering Myeloma

ASH 2024 HealthTree’s Oral Presentation on How Side Effects Influence Myeloma Patients’ Decisions

Dec. 09, 2024

ASH 2024 HealthTree’s Oral Presentation on How Side Effects Influence Myeloma Patients’ Decisions

ASH 2024: HealthTree Shares What Treatments Myeloma Patients Prefer

Dec. 09, 2024

ASH 2024: HealthTree Shares What Treatments Myeloma Patients Prefer

Recent Articles

A Busy Myeloma Day at the 2024 ASH Conference image

A Busy Myeloma Day at the 2024 ASH Conference

December 07, 2024

Today, several sessions at the American Society of Hematology conference will cover myeloma research updates. Stay tuned!

FDA Reviews Belantamab Mafodotin for Approval in Relapsed/Refractory Multiple Myeloma image

FDA Reviews Belantamab Mafodotin for Approval in Relapsed/Refractory Multiple Myeloma

December 05, 2024

FDA reviews belantamab mafodotin for relapsed multiple myeloma, the decision is expected by July 2025.

What is the ASH Conference? image

What is the ASH Conference?

December 02, 2024

The American Society of Hematology's annual conference is a significant event for the blood cancer community, including those involved in myeloma research.

Treatment Advances

FDA Reviews Belantamab Mafodotin for Approval in Relapsed/Refractory Multiple Myeloma image

FDA Reviews Belantamab Mafodotin for Approval in Relapsed/Refractory Multiple Myeloma

BRCA Gene Testing in Multiple Myeloma: New Research Reveals Treatment Insights image

BRCA Gene Testing in Multiple Myeloma: New Research Reveals Treatment Insights

Myeloma Treatments that Target the Microenvironment image

Myeloma Treatments that Target the Microenvironment

New Treatment Coming for High-Risk Smoldering Myeloma? image

New Treatment Coming for High-Risk Smoldering Myeloma?

How Myeloma Induction Therapy Is Evolving: Vital Insights for Newly Diagnosed Patients image

How Myeloma Induction Therapy Is Evolving: Vital Insights for Newly Diagnosed Patients

Taking a Break from Lenalidomide Maintenance image

Taking a Break from Lenalidomide Maintenance

Load More

Core Education

What Is the Best Consolidation/Maintenance Therapy for People with Myeloma? image

What Is the Best Consolidation/Maintenance Therapy for People with Myeloma?

A Better Understanding of Multiple Myeloma Biology image

A Better Understanding of Multiple Myeloma Biology

What is Pancytopenia? Symptoms, Causes, & Treatments image

What is Pancytopenia? Symptoms, Causes, & Treatments

What is Light-Chain Only Myeloma? image

What is Light-Chain Only Myeloma?

What Is the Prognosis of a Multiple Myeloma Patient? image

What Is the Prognosis of a Multiple Myeloma Patient?

When Does Smoldering Myeloma Become Active Myeloma? image

When Does Smoldering Myeloma Become Active Myeloma?

Load More

Trending Articles

What Can Be Done to Predict Optimal CAR-T Responses?

HealthTree Research: Patients Share their Experiences with Talquetamab Therapy

Landmark Study Shows Daratumumab Significantly Delays Progression in Smoldering Myeloma

Studying Quality of Life With and Without Elotuzumab in Newly Diagnosed Myeloma

What is Light-Chain Only Myeloma?

Upcoming Events

Driving New Discoveries in Myeloma Research with Dr. Brian Van Ness from the University of Minnesota

Driving New Discoveries in Myeloma Research with Dr. Brian Van Ness from the University of Minnesota

Jan 06 / 12:00 MST

Practical Tips for Multiple Myeloma Patients: Simple Strategies to Add More Add Fruits and Vegetables to Your Plate or Transition to a Plant-Based Diet

Practical Tips for Multiple Myeloma Patients: Simple Strategies to Add More Add Fruits and Vegetables to Your Plate or Transition to a Plant-Based Diet

Jan 14 / 15:00 EST

Patient Stories

articles for Patient Stories

Defining Herself By Her Cancer? Terry Glassman’s Journey with Myeloma and Plasma Cell Leukemia Finding Strength in Love: Cindy Capps’ Journey as a Caregiver for Two Myeloma Patients A Myeloma Caregiver’s Journey: Barb Mower’s Practical Insights and Hard-Earned Advice

HealthTree Research

articles for HealthTree Research

HealthTree Study: How Do Myeloma Patients Feel About Using Cannabis? HealthTree Research: Patients Share their Experiences with Talquetamab Therapy Results from HealthTree Study Presented at ASH 2024: Managing Pain and Opioid Use for Myeloma Patients

Conferences

articles for Conferences

Studying Quality of Life With and Without Elotuzumab in Newly Diagnosed Myeloma What Can Be Done to Predict Optimal CAR-T Responses? Does 24-Hour Urine Testing Add Value to Myeloma Response Results?

Clinical Trials

articles for Clinical Trials

New CAR T for Relapsed/Refractory Myeloma Shows Promising Phase 1 Results What are Clinical Trials, and How May They Help Me? Can Yoga Help Myeloma Patients on Active Treatment?

HealthTree Press

articles for HealthTree Press

Philadelphia’s Role in Biotech Innovation - Alongside Myeloma Coaches HealthTree Coaches Share Their Experiences About Navigating Mental Health and Finances HealthTree Foundation Featured on Fox News

HealthTree Programs

articles for HealthTree Programs

Join the Black Myeloma Health Movement for Research Unlocking Bispecific Antibody Therapy: A Comprehensive Guide for the Myeloma Community The Future of Blood Cancer: Advances in Detection, Treatment, and Research

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson

Sanofi

Pfizer

Genentech

Regeneron

Adaptive

Follow Us

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2024 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811